Suppr超能文献

门静脉高压症中的肺血管疾病

Pulmonary vascular disorders in portal hypertension.

作者信息

Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P

机构信息

Service de Pneumologie et Réanimation, Hôpital Antoine Béclère, Clamart, France.

出版信息

Eur Respir J. 1998 May;11(5):1153-66. doi: 10.1183/09031936.98.11051153.

Abstract

The wide spectrum of pulmonary vascular disorders in liver disease and portal hypertension ranges from the hepatopulmonary syndrome characterized by intrapulmonary vascular dilatations, to pulmonary hypertension (portopulmonary hypertension), in which pulmonary vascular resistance is elevated. Since hepatopulmonary syndrome and portopulmonary hypertension have been reported in patients with nonhepatic portal hypertension, the common factor that determines their development must be portal hypertension. The clinical presentations are very different, with gas exchange impairment in the hepatopulmonary syndrome and haemodynamic failure in portopulmonary hypertension. The severity of hepatopulmonary syndrome seems to parallel the severity of liver failure, whereas no simple relationship has been identified between hepatic impairment and the severity of portopulmonary hypertension. Resolution of hepatopulmonary syndrome is common after liver transplantation, which has an uncertain effect in portopulmonary hypertension. The pathophysiology of both syndromes may involve vasoactive mediators and angiogenic factors.

摘要

肝病和门脉高压症中广泛的肺血管疾病谱,涵盖了以肺内血管扩张为特征的肝肺综合征,到肺血管阻力升高的肺动脉高压(门脉性肺动脉高压)。由于在非肝门脉高压患者中也有肝肺综合征和门脉性肺动脉高压的报道,决定其发生的共同因素必定是门脉高压。临床表现差异很大,肝肺综合征有气体交换受损,而门脉性肺动脉高压有血流动力学衰竭。肝肺综合征的严重程度似乎与肝衰竭的严重程度平行,而肝损害与门脉性肺动脉高压的严重程度之间尚未发现简单的关系。肝肺综合征在肝移植后通常会缓解,而对门脉性肺动脉高压的影响尚不确定。这两种综合征的病理生理学可能都涉及血管活性介质和血管生成因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验